EMD Serono, USA
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany

Facts & Figures

We are the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. We focus exclusively on specialty care - integrating cutting-edge science with industry-leading patient support.

leading marketed products in the US

patients helped through our support services

∼ 5M/year
donated to community organizations and non-profits

joint compounds in development
Therapeutic Areas of Focus
  • Neurology
  • Fertility
  • Endocrinology
  • Oncology
  • Immuno-Oncology
  • Immunology

Our Leadership Team

Our Global Organization

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, is a specialized biopharmaceutical company dedicated to developing therapies with groundbreaking potential.

Global Biopharamaceutical Division By the Numbers:
• €6B Total Revenues (2013)
• €1.2B R&D Investment (2013)
• ∼ 150 countries in which products are marketed
• ∼ 30 compounds in development

As part of Merck KGaA, Darmstadt, Germany we are uniquely positioned to transform the stability and power of a globally networked organization into the direct impact of targeted, personal service for our customers.


We have three locations in the US plus field employees in clinical trial management, sales, and key commercial operations.




Research & Development Institute


Government Affairs


About Us

A leader in specialty care

At EMD Serono, we recognized the potential of specialty pharmaceuticals and patient care long ago, and have been dedicated to delivering on their promise ever since.

We have a legacy of both trying to find solutions to hard to treat conditions, as well as developing patient assistance programs that help ensure that those who need our therapies are able to access them.

As one of the top five U.S. companies exclusively focused on specialty care, we see our innovation as a matter of balancing science with emotion – integrating our top minds in research and development with the insights from patients and health care practitioners confronting real- world concerns.